This has been a big year for the HIV community. One key event was June 5 — which marked 30 years since the first reported cases of AIDS in the United States. As one of the many efforts to recognize this important milestone, the U.S. Department of Health and Human Services (HHS) developed a series…
6th International AIDS Society Conference Underway This Week
July 18, 2011 • 0 comments • By Miguel Gomez, Director, AIDS.gov, and Senior Communications Advisor, Office of HIV/AIDS Policy, U.S. Department of Health and Human Services
This week, over 5,000 delegates from around the world are attending the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) in Rome, Italy. This biannual conference is the world’s largest open scientific conference on HIV/AIDS, and provides “a unique opportunity for the world’s leading scientists, clinicians, public health experts and…
The Future of the NIAID Clinical Trial Units
June 28, 2011 • 2 comments • By Manizhe Payton, Director, Office of Clinical Oversight, Division of AIDS, National Institute of Allergy and Infectious Diseases
As the National Institute of Allergy and Infectious Diseases (NIAID) moves forward to restructure its HIV/AIDS Clinical Trials Networks and include a new network focused on infectious diseases other than AIDS, the Clinical Trial Units (CTUs) will continue to play a critical role in establishing, developing, and implementing the networks’ scientific research agendas. Additionally, we…
FDA and FTC Act to Remove Fraudulent HIV and STD Products from the Market
June 9, 2011 • 0 comments • By Miguel Gomez, Director, AIDS.gov, and Senior Communications Advisor, Office of HIV/AIDS Policy, U.S. Department of Health and Human Services
Last month the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) announced a joint effort to remove products from the market that make unproven claims to treat, cure, and prevent sexually transmitted diseases (STDs), including HIV/AIDS. Among the products targeted in the action are Medavir, Herpaflor, Viruxo, C-Cure, and Never An…
What You Missed: Open for Questions 30 Years of AIDS
Yesterday, Surgeon General Dr. Regina Benjamin, Director of the White House Office of National AIDS Policy Jeffrey Crowley and Director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, NIH, Dr. Carl Dieffenbach came to the White House for a special live chat on 30th anniversary of the AIDS epidemic….
Upcoming Event: NIH’s Dr. Fauci’s Talk “Thirty Years of HIV/AIDS: A Personal Journey”
May 23, 2011 • 0 comments • By Miguel Gomez, Director, AIDS.gov, and Senior Communications Advisor, Office of HIV/AIDS Policy, U.S. Department of Health and Human Services
June 5, 2011 will mark 30 years since the first cases of AIDS were reported in the U.S. On Tuesday, May 31, at 2pm ET, Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), will be giving a talk, “Thirty Years of HIV/AIDS:…
HIV Vaccine Awareness Day, 2011
May 17, 2011 • 1 comment • By Anthony Fauci, M.D., Director, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health
Cross-posted from Office of National AIDS Policy Blog
Cross-posted from Office of National AIDS Policy Blog
Co-authored by Margaret (Peggy) Johnston, Ph.D., Senior Scientific Consultant, NIAID.
HIV Vaccine Awareness Day provides an opportunity to acknowledge the more than 35,000 individuals who have volunteered for preventive HIV vaccine trials over the past 25 years. Without their participation, the modest success that we have achieved…